Global Mesalazine Market Insights and Forecast to 2027

1 Study Coverage

• 1.1 Mesalazine Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Mesalazine Market Size Growth Rate by Type
  • 1.4.2 Purity ≥ 97 %
  • 1.4.3 Purity ≥ 98 %
  • 1.2.4 Purity ≥ 99 %
• 1.3 Market by Application
  • 1.3.1 Global Mesalazine Market Size Growth Rate by Application
  • 1.3.2 Mesalazine Tablets
  • 1.3.3 Mesalazine Capsules
  • 1.3.4 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Executive Summary

• 2.1 Global Mesalazine Sales Estimates and Forecasts 2016-2027
• 2.2 Global Mesalazine Revenue Estimates and Forecasts 2016-2027
• 2.3 Global Mesalazine Revenue by Region: 2016 VS 2021 VS 2027
• 2.4 Global Top Mesalazine Regions by Sales
  • 2.4.1 Global Top Mesalazine Regions by Sales (2016-2021)
  • 2.4.2 Global Top Mesalazine Regions by Sales (2022-2027)
• 2.5 Global Top Mesalazine Regions by Revenue
  • 2.5.1 Global Top Mesalazine Regions by Revenue (2016-2021)
  • 2.5.2 Global Top Mesalazine Regions by Revenue (2022-2027)
• 2.6 North America
• 2.7 Europe
• 2.8 Asia-Pacific
• 2.9 Latin America
• 2.10 Middle East & Africa

3 Competition by Manufacturers

• 3.1 Global Mesalazine Sales by Manufacturers
  • 3.1.1 Global Top Mesalazine Manufacturers by Sales (2016-2021)
  • 3.1.2 Global Top Mesalazine Manufacturers Market Share by Sales (2016-2021)
  • 3.1.3 Global Top 10 and Top 5 Companies by Mesalazine Sales in 2020
• 3.2 Global Mesalazine Revenue by Manufacturers
  • 3.2.1 Global Top Mesalazine Manufacturers by Revenue (2016-2021)
  • 3.2.2 Global Top Mesalazine Manufacturers Market Share by Revenue (2016-2021)
  • 3.2.3 Global Top 10 and Top 5 Companies by Mesalazine Revenue in 2020
• 3.3 Global Mesalazine Sales Price by Manufacturers
• 3.4 Analysis of Competitive Landscape
  • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Mesalazine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.4.3 Global Mesalazine Manufacturers Geographical Distribution
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Global Mesalazine Sales by Type
  • 4.1.1 Global Mesalazine Historical Sales by Type (2016-2021)
  • 4.1.2 Global Mesalazine Forecasted Sales by Type (2022-2027)
  • 4.1.3 Global Mesalazine Sales Market Share by Type (2016-2027)
• 4.2 Global Mesalazine Revenue by Type
  • 4.2.1 Global Mesalazine Historical Revenue by Type (2016-2021)
  • 4.2.2 Global Mesalazine Forecasted Revenue by Type (2022-2027)
  • 4.2.3 Global Mesalazine Revenue Market Share by Type (2016-2027)
• 4.3 Global Mesalazine Price by Type
  • 4.3.1 Global Mesalazine Price by Type (2016-2021)
  • 4.3.2 Global Mesalazine Price Forecast by Type (2022-2027)

5 Market Size by Application

• 5.1 Global Mesalazine Sales by Application
  • 5.1.1 Global Mesalazine Historical Sales by Application (2016-2021)
  • 5.1.2 Global Mesalazine Forecasted Sales by Application (2022-2027)
  • 5.1.3 Global Mesalazine Sales Market Share by Application (2016-2027)
• 5.2 Global Mesalazine Revenue by Application
  • 5.2.1 Global Mesalazine Historical Revenue by Application (2016-2021)
  • 5.2.2 Global Mesalazine Forecasted Revenue by Application (2022-2027)
  • 5.2.3 Global Mesalazine Revenue Market Share by Application (2016-2027)
• 5.3 Global Mesalazine Price by Application
  • 5.3.1 Global Mesalazine Price by Application (2016-2021)
  • 5.3.2 Global Mesalazine Price Forecast by Application (2022-2027)

6 North America

• 6.1 North America Mesalazine Market Size by Type
  • 6.1.1 North America Mesalazine Sales by Type (2016-2027)
  • 6.1.2 North America Mesalazine Revenue by Type (2016-2027)
• 6.2 North America Mesalazine Market Size by Application
  • 6.2.1 North America Mesalazine Sales by Application (2016-2027)
  • 6.2.2 North America Mesalazine Revenue by Application (2016-2027)
• 6.3 North America Mesalazine Market Size by Country
  • 6.3.1 North America Mesalazine Sales by Country (2016-2027)
  • 6.3.2 North America Mesalazine Revenue by Country (2016-2027)
  • 6.3.3 U.S.
  • 6.3.4 Canada

7 Europe

• 7.1 Europe Mesalazine Market Size by Type
  • 7.1.1 Europe Mesalazine Sales by Type (2017-2027)
  • 7.1.2 Europe Mesalazine Revenue by Type (2017-2027)
• 7.2 Europe Mesalazine Market Size by Application
  • 7.2.1 Europe Mesalazine Sales by Application (2017-2027)
  • 7.2.2 Europe Mesalazine Revenue by Application (2017-2027)
• 7.3 Europe Mesalazine Market Size by Country
  • 7.3.1 Europe Mesalazine Sales by Country (2017-2027)
  • 7.3.2 Europe Mesalazine Revenue by Country (2017-2027)
  • 7.3.3 Germany
  • 7.3.4 France
  • 7.3.5 U.K.
  • 7.3.6 Italy
  • 7.3.7 Russia

8 Asia Pacific

• 8.1 Asia Pacific Mesalazine Market Size by Type
  • 8.1.1 Asia Pacific Mesalazine Sales by Type (2018-2027)
  • 8.1.2 Asia Pacific Mesalazine Revenue by Type (2018-2027)
• 8.2 Asia Pacific Mesalazine Market Size by Application
  • 8.2.1 Asia Pacific Mesalazine Sales by Application (2018-2027)
  • 8.2.2 Asia Pacific Mesalazine Revenue by Application (2018-2027)
• 8.3 Asia Pacific Mesalazine Market Size by Region
  • 8.3.1 Asia Pacific Mesalazine Sales by Region (2018-2027)
  • 8.3.2 Asia Pacific Mesalazine Revenue by Region (2018-2027)
  • 8.3.3 China
  • 8.3.4 Japan
  • 8.3.5 South Korea
  • 8.3.6 India
  • 8.3.7 Australia
  • 8.3.8 Taiwan
  • 8.3.9 Indonesia
  • 8.3.10 Thailand
  • 8.3.11 Malaysia
  • 8.3.12 Philippines

9 Latin America

• 9.1 Latin America Mesalazine Market Size by Type
  • 9.1.1 Latin America Mesalazine Sales by Type (2019-2027)
  • 9.1.2 Latin America Mesalazine Revenue by Type (2019-2027)
• 9.2 Latin America Mesalazine Market Size by Application
  • 9.2.1 Latin America Mesalazine Sales by Application (2019-2027)
  • 9.2.2 Latin America Mesalazine Revenue by Application (2019-2027)
• 9.3 Latin America Mesalazine Market Size by Country
  • 9.3.1 Latin America Mesalazine Sales by Country (2019-2027)
  • 9.3.2 Latin America Mesalazine Revenue by Country (2019-2027)
  • 9.3.3 Mexico
  • 9.3.4 Brazil
  • 9.3.5 Argentina

6 Middle East and Africa

• 6.1 Middle East and Africa Mesalazine Market Size by Type
  • 6.1.1 Middle East and Africa Mesalazine Sales by Type (2016-2027)
  • 6.1.2 Middle East and Africa Mesalazine Revenue by Type (2016-2027)
• 6.2 Middle East and Africa Mesalazine Market Size by Application
  • 6.2.1 Middle East and Africa Mesalazine Sales by Application (2016-2027)
  • 6.2.2 Middle East and Africa Mesalazine Revenue by Application (2016-2027)
• 6.3 Middle East and Africa Mesalazine Market Size by Country
  • 6.3.1 Middle East and Africa Mesalazine Sales by Country (2016-2027)
  • 6.3.2 Middle East and Africa Mesalazine Revenue by Country (2016-2027)
  • 6.3.3 Turkey
  • 6.3.4 Saudi Arabia
  • 6.3.5 U.A.E

11 Company Profiles

• 11.1 Syntese A/S
  • 11.1.1 Syntese A/S Corporation Information
  • 11.1.2 Syntese A/S Overview
  • 11.1.3 Syntese A/S Mesalazine Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.1.4 Syntese A/S Mesalazine Product Description
  • 11.1.5 Syntese A/S Related Developments
• 11.2 Divis Laboratories
  • 11.2.1 Divis Laboratories Corporation Information
  • 11.2.2 Divis Laboratories Overview
  • 11.2.3 Divis Laboratories Mesalazine Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.2.4 Divis Laboratories Mesalazine Product Description
  • 11.2.5 Divis Laboratories Related Developments
• 11.3 Cambrex Corporation
  • 11.3.1 Cambrex Corporation Corporation Information
  • 11.3.2 Cambrex Corporation Overview
  • 11.3.3 Cambrex Corporation Mesalazine Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.3.4 Cambrex Corporation Mesalazine Product Description
  • 11.3.5 Cambrex Corporation Related Developments
• 11.4 Ipca Laboratories
  • 11.4.1 Ipca Laboratories Corporation Information
  • 11.4.2 Ipca Laboratories Overview
  • 11.4.3 Ipca Laboratories Mesalazine Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.4.4 Ipca Laboratories Mesalazine Product Description
  • 11.4.5 Ipca Laboratories Related Developments
• 11.5 PharmaZell
  • 11.5.1 PharmaZell Corporation Information
  • 11.5.2 PharmaZell Overview
  • 11.5.3 PharmaZell Mesalazine Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.5.4 PharmaZell Mesalazine Product Description
  • 11.5.5 PharmaZell Related Developments
• 11.6 Lasa Loboratory
  • 11.6.1 Lasa Loboratory Corporation Information
  • 11.6.2 Lasa Loboratory Overview
  • 11.6.3 Lasa Loboratory Mesalazine Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.6.4 Lasa Loboratory Mesalazine Product Description
  • 11.6.5 Lasa Loboratory Related Developments
• 11.7 Erregierre SpA
  • 11.7.1 Erregierre SpA Corporation Information
  • 11.7.2 Erregierre SpA Overview
  • 11.7.3 Erregierre SpA Mesalazine Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.7.4 Erregierre SpA Mesalazine Product Description
  • 11.7.5 Erregierre SpA Related Developments
• 11.8 Corden Pharma Bergamo
  • 11.8.1 Corden Pharma Bergamo Corporation Information
  • 11.8.2 Corden Pharma Bergamo Overview
  • 11.8.3 Corden Pharma Bergamo Mesalazine Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.8.4 Corden Pharma Bergamo Mesalazine Product Description
  • 11.8.5 Corden Pharma Bergamo Related Developments
• 11.9 CTX Lifescience
  • 11.9.1 CTX Lifescience Corporation Information
  • 11.9.2 CTX Lifescience Overview
  • 11.9.3 CTX Lifescience Mesalazine Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.9.4 CTX Lifescience Mesalazine Product Description
  • 11.9.5 CTX Lifescience Related Developments
• 11.10 Ishita Active Pharma Ingredients
  • 11.10.1 Ishita Active Pharma Ingredients Corporation Information
  • 11.10.2 Ishita Active Pharma Ingredients Overview
  • 11.10.3 Ishita Active Pharma Ingredients Mesalazine Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.10.4 Ishita Active Pharma Ingredients Mesalazine Product Description
  • 11.10.5 Ishita Active Pharma Ingredients Related Developments
• 11.1 Syntese A/S
  • 11.1.1 Syntese A/S Corporation Information
  • 11.1.2 Syntese A/S Overview
  • 11.1.3 Syntese A/S Mesalazine Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.1.4 Syntese A/S Mesalazine Product Description
  • 11.1.5 Syntese A/S Related Developments
• 11.12 Xinxiang Tianfeng Fine Chemical
  • 11.12.1 Xinxiang Tianfeng Fine Chemical Corporation Information
  • 11.12.2 Xinxiang Tianfeng Fine Chemical Overview
  • 11.12.3 Xinxiang Tianfeng Fine Chemical Mesalazine Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.12.4 Xinxiang Tianfeng Fine Chemical Product Description
  • 11.12.5 Xinxiang Tianfeng Fine Chemical Related Developments

12 Value Chain and Sales Channels Analysis

• 12.1 Mesalazine Value Chain Analysis
• 12.2 Mesalazine Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Mesalazine Production Mode & Process
• 12.4 Mesalazine Sales and Marketing
  • 12.4.1 Mesalazine Sales Channels
  • 12.4.2 Mesalazine Distributors
• 12.5 Mesalazine Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

• 13.1 Mesalazine Industry Trends
• 13.2 Mesalazine Market Drivers
• 13.3 Mesalazine Market Challenges
• 13.4 Mesalazine Market Restraints

14 Key Findings in The Global Mesalazine Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Author Details